$BMRA News

Last published 3w ago

3w agoBMRABiomerica Reports First Quarter Fiscal 2027 Financial ResultsGlobeNewswireInFoods® IBS Commercial Progress: Medicare-related test orders increased 120% in September 2026 compared to August, with growing physician participation and repeat ordering activityInFoods® IBS update: 100% of all
2mo agoBMRABiomerica Reports Fiscal 2026 Year-End Financial ResultsGlobeNewswireFiscal 2026 fourth quarter net sales increased approximately 17% compared to the fourth quarter of fiscal 2025Full-year net loss improved by approximately 24% to approximately $3.8 millionInFoods IBS update: 100% of all
2mo agoBMRABiomerica Announces $2.23 Million FinancingGlobeNewswireFinancing priced at $1.60 with no warrants or discountB. Riley Principal Capital and B. Riley executives, as well as Biomerica's CEO and all members of Biomerica’s Board of Directors participated in the
5mo agoBMRABiomerica Lands a $1.75 Million CDMO Master Services Agreement for IVD Diagnostic DevelopmentGlobeNewswireIRVINE, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ:BMRA), a developer and manufacturer of diagnostic test systems and CDMO services provider, today announced it has entered into a Master Services
5mo agoBMRAConsumerDirect Expands Executive Team with Appointment of Gary Lu, CPA as Chief Financial OfficerBusiness WireVeteran finance and operations leader brings more than 20 years of experience across public companies and high-growth organizations ConsumerDirect Inc., an industry leader in helping consumers manage their credit,
6mo agoBMRABiomerica's inFoods® IBS Data Accepted for Presentation at Digestive Disease Week 2026GlobeNewswireIRVINE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ:BMRA), a global biomedical technology company focused on innovative diagnostic-guided therapies, today announced that an abstract evaluating
6mo agoBMRABiomerica Announces Medicare Administrative Contractor Confirmation of Individual Claim Review for inFoods® IBS, Opening a Scalable Medicare Commercialization PathwayGlobeNewswireThe Medicare Administrative Contractor (MAC) responsible for processing inFoods® IBS claims has confirmed to Biomerica's certified laboratory partner that the test will be reviewed on an individual, claim-by-claim
7mo agoBMRABiomerica Launches inFoods® IBS in Canada Through Partnerships with Phoenix Airmid Biomedical and CanAlt Health LabsGlobeNewswire— Represents Biomerica's First Commercial Entry into the Canadian Market for its Precision, Diagnostic-Guided Therapy — Canada Has One of the Highest IBS Prevalence Rates in the World — an Estimated 18% vs. 11% Globally
7mo agoBMRABiomerica Reports Third Quarter Fiscal 2026 Financial ResultsGlobeNewswireIRVINE, Calif., April 13, 2026 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ:BMRA), ("Biomerica" or the "Company") a global provider of advanced medical diagnostic and therapeutic products today reported financial
8mo agoBMRABiomerica Receives MHRA Registration for hp+detect™, Allowing Commercial Sales in Great BritainGlobeNewswireUK Market Entry: MHRA registration authorizes hp+detect™ for commercial sale in Great BritainActive Commercialization: Biomerica is in active discussions with UK partners to access the diagnostic laboratory market
8mo agoBMRA HSICBiomerica Reports Real-World Data: Nearly 60% of IBS Patients Achieved Clinically Meaningful Pain Reduction and 68% Achieved Bloating Reduction with the inFoods® IBS TherapyGlobeNewswireKey Highlights Responder Analysis: 59.4% of patients achieved ≥30% reduction in abdominal pain; 68.1% achieved ≥30% reduction in bloating—using the FDA-recognized responder endpoint consistent with the Company's
8mo agoBMRAVietnam Approves Biomerica's EZ Detect™ for Nationwide DistributionGlobeNewswireApproval Marks Biomerica's Strategic Entry into Southeast Asia's Rapidly Growing Healthcare MarketSimple, FDA-Cleared At-Home Test Detects an Early Warning Sign of Colorectal Cancer in Minutes IRVINE, Calif., Feb. 18,
10mo agoBMRABiomerica Reports Second Quarter Fiscal 2026 Financial ResultsGlobeNewswireOperating Expenses Decline 4% Year-to-DateBalance Sheet Strengthens and Working Capital Improves by 14.7% IRVINE, Calif., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ:BMRA), (the "Company") a global
10mo agoBMRABiomerica Announces CMS Medicare Payment Rate of $300 for Revolutionary inFoods® IBS TestGlobeNewswireCMS is the single largest payer for healthcare in the United States, with Medicare responsible for approximately 21% of total healthcare expenditure.The $300 rate will apply to claims approved and paid by Medicare with
11mo agoBMRAEgyptian Drug Authority Authorizes Biomerica's Complete Screening Test PortfolioGlobeNewswireAuthorization Covers Multiple Screening Tests for Cancer and Chronic Disease Risk Detection • Portfolio includes tests for colorectal disease, breast self exam, prostate disease, kidney disease, and H. pylori infection
11mo agoBMRABiomerica's inFoods® IBS Product Featured in Biotherapeutics Quarterly, a Henry Schein Publication, Highlighting a New Precision Approach for Treating IBSGlobeNewswirePublication details large multicenter clinical trial demonstrating significant reductions in IBS symptoms through inFoods IBS guided dietary therapy IRVINE, Calif., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc.
1y agoBMRABiomerica Expands Contract Development and Manufacturing Services to Meet Growing Market DemandGlobeNewswireRising Demand from Third-Party Diagnostic and Biotechnology Companies Drives CDMO Service ExpansionComprehensive CDMO services now featured on Biomerica's updated website IRVINE, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE)
1y agoBMRA HSICHenry Schein and Biomerica Enter into Marketing Services Agreement for Biomerica's inFoods® IBS Test in the U.S.GlobeNewswire- Expands Marketing of Non-Drug IBS Symptom Management Test Through One of the Nation's Most Trusted Health Care Distributors- Relationship Marks a Key Milestone in Biomerica's Commercialization Strategy IRVINE,
1y agoBMRABiomerica Reports First Quarter Fiscal 2026 Financial ResultsGlobeNewswireReported Improved Gross Margin from Contribution from Higher-Margin Product MixOperating Expenses Continued to Decline Compared to the First Quarter of the Prior Fiscal Year, Reflecting the Company's Ongoing Focus on
1y agoBMRAGary Huff, Former CEO of LabCorp Diagnostics, Appointed to Biomerica Board of DirectorsGlobeNewswireBrings decades of leadership in laboratory testing, clinical diagnostics, payor strategy, and sales growth Extensive track record in commercializing advanced laboratory testing and insurer strategies IRVINE, Calif.,
1y agoBMRABiomerica Launches AI-Backed inFoods® IBS Trigger Food Navigator to Support Personalized IBS Therapy and Improve Patient OutcomesGlobeNewswireNew AI-enabled digital tool empowers patients to confidently manage IBS symptoms and avoid the trigger foods identified by inFoods® IBS testingIBS affects an estimated 40 million adults in the U.S. and hundreds of
1y agoBMRAUnited Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Kidney Test for Home UseGlobeNewswire10-minute home test detects early kidney damage in diabetic and hypertensive patientsHypertension affects roughly one-third of adults in the UAEDiabetes impacts approximately one in four UAE nationals IRVINE, Calif.,
1y agoBMRABiomerica Reports Fiscal 2025 Year End ResultsGlobeNewswire$1.3 Million in Operating Expense Reductions Achieved– Operating Loss Improves 19% Year-Over-YearResilient Portfolio Performance with International Sales Despite Global Economic UncertaintiesCash Used in Operating
1y agoBMRAUnited Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Ulcer Test for Home UseGlobeNewswire10-minute home test enables detection of Helicobacter pylori, a leading cause of peptic ulcers, dyspepsia, and gastric cancerH. pylori linked to approximately 80% of gastric cancer cases; classified as a Class 1
1y agoBMRAInFoods IBS receives CPT® Proprietary Laboratory Analysis (PLA) CodeGlobeNewswirePLA Code issuance by the American Medical Association CPT editorial panel marks a meaningful step toward attaining health insurance reimbursement and expanded patient access for inFoods® IBSinFoods® IBS
1y agoBMRAClinical Diagnostics Industry Leader Scott Madel Joins Biomerica's Team as Chief Commercial OfficerGlobeNewswireBrings 20+ years of revenue growth leadership in laboratory testing, clinical diagnostics and global expansionLed successful organizational turnarounds and growth strategies at both Boston Heart Diagnostics and Genova
1y agoBMRABiomerica Appoints Eric B. Chin to Board of Directors and Audit Committee ChairGlobeNewswireMr. Chin brings over 20 years of financial experience across public and private healthcare organizationsMr. Chin currently serves as CFO of Akido Labs where he successfully helped raise $60 million in a recent
1y agoBMRABiomerica's inFoods® IBS Clinical Study Results Published in June Issue of GastroenterologyGlobeNewswireLandmark Peer-Reviewed Study Demonstrates Effectiveness of Personalized Dietary Therapy for IBS Patients Using inFoods® IBS Test.Gastroenterology, the premier journal in gastrointestinal science, features data
1y agoBMRABiomerica Reports Real-World Data Showing 49% Reduction in IBS Symptoms with inFoods® IBS using a First of Its Kind Real-Time IBS Patient Feedback SystemGlobeNewswireReal-World Impact: Initial data from over 360 patients shows inFoods® IBS delivered an average 48.5% reduction in gastrointestinal pain and a 49.8% reduction in bloating over an 8-week period First-of-Its-Kind
1y agoBMRAPLA Code Application Filed for inFoods IBS Test — A Key Step Toward ReimbursementGlobeNewswire- Application represents milestone toward broadening patient access to inFoods IBS - inFoods® IBS pinpoints patient-specific foods that can trigger IBS symptoms like bloating, abdominal pain, diarrhea,
1y agoBMRAUnited Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Ulcer Test for Detection of H. pylori InfectionGlobeNewswire10-minute test enables detection of Helicobacter pylori, a leading cause of peptic ulcers, dyspepsia, and gastric cancerApproximately 80% of gastric cancer cases are linked to H. pylori infection; WHO classifies H.
1y agoBMRAUnited Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Kidney Disease Test for Early Detection of Kidney DamageGlobeNewswireRegulatory milestone enables commercial expansion into high-need international market10-minute test detects early signs of kidney damage using a simple urine sample Addresses global public health burden of Chronic Kidney
1y agoBMRABiomerica Announces Reverse Stock SplitGlobeNewswireIRVINE, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ:BMRA) ("Biomerica"), a global provider of advanced medical products, today announced that it will implement a 1-for-8 reverse stock split of
1y agoBMRABiomerica Reports Third Quarter Fiscal 2025 Financial ResultsGlobeNewswireTotal Revenue Increases 10% Year-Over-YearDelivers Improved Gross Margins, Achieves Annual Cost Savings Target Early, and Reduces Cash Burn Over 55% IRVINE, Calif., April 15, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc.
1y agoBMRABiomerica Achieves IVDR Certification in the European Union for Food Intolerance Tests Targeting Crohn's Disease and Ulcerative ColitisGlobeNewswireSignificant Milestone: Biomerica secures IVDR (In Vitro Diagnostic Regulation) certification, ensuring compliance with stringent European Union standards and allowing sales of the products in the EUFocus on Precision
1y agoBMRABiomerica's inFoods® IBS Clinical Trial Results Published and Featured in Gastroenterology, the Leading GI Medical JournalGlobeNewswireinFoods IBS Provides Personalized Diet Therapy for Patients Suffering with Irritable Bowel Syndrome (IBS)Research Finds Patients Following a Personalized Diet Therapy Created with inFoods® IBS, Experienced Reduced
1y agoBMRAUnited Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® PSA Screening Test to Detect an Early Sign of Prostate CancerGlobeNewswire- 10-Minute PSA Test for Early Detection of Prostate Specific Antigen (PSA), an Early Warning Sign of Prostate Cancer - Prostate Cancer: The Second Most Common Cancer in Men Globally IRVINE, Calif., Jan. 16, 2025
1y agoBMRABiomerica Reports Second Quarter Fiscal 2025 Financial ResultsGlobeNewswire- Total Revenue Increases 5% Year-Over-Year - Achieves Sustained Revenue Growth, Improved Gross Margins, and Significant Cost Savings IRVINE, Calif., Jan. 15, 2025 (GLOBE
1y agoBMRABiomerica Secures Three Key International Patents for inFoods® Technology to Address GERD, Crohn's Disease, and Ulcerative ColitisGlobeNewswireNew patents position Biomerica to address multi-billion-dollar markets in Europe, including GERD ($4 billion+), Crohn's Disease ($2.5 billion+), and Ulcerative Colitis ($1.9 billion+) The company received three
2y agoBMRANasdaq grants Biomerica an additional 180 days to meet listing compliance requirementsGlobeNewswireIRVINE, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ:BMRA), a leading global provider of advanced medical diagnostics, announced that it has been granted an additional 180-day compliance period
2y agoBMRABiomerica Announces Direct-to-Consumer Availability of inFoods® IBS Test, Targeting Relief for Bloating and Gastrointestinal PainGlobeNewswirePatients experiencing bloating and gastrointestinal discomfort can now order inFoods® IBS directly from www.infoodsIBS.com without needing to visit a doctor's officeWith a simple, at-home finger-prick blood sample,
2y agoBMRABiomerica Reports First Quarter Fiscal 2025 Financial ResultsGlobeNewswireTotal Revenue Increases 6% Over Same Period Last Year Cost-Saving Measures Now Implemented, Expected to Reduce Annual Expenses by 16% to 23%, Representing $1.0 to $1.4 Million ReductionBiomerica's
2y agoBMRAThe Saudi Food and Drug Authority (SFDA) Approves Biomerica's At Home PSA Screening Test to Detect Early Signs of Prostate CancerGlobeNewswire- 10-Minute At-Home PSA Test for Early Detection of Prostate Cancer - First order already shipped to Saudi Arabia - Prostate Cancer is the Second Most Common Cancer in Men Globally IRVINE, Calif., Sept.
2y agoBMRABiomerica Reports Fiscal 2024 Year End ResultsGlobeNewswireTotal Revenue Increases 1% Year-Over-Year – Core Revenue Excluding COVID Tests Climbs 5%, Reflecting Stronger GrowthSignificant Cost Savings Plan Implemented After Year End – Expected to Deliver Expense Reductions of
2y agoBMRABiomerica Launches At-Home Sample Collection for inFoods® IBS, Significantly Expanding Access for Millions of IBS SufferersGlobeNewswireinFoods® IBS patients can now conveniently self-collect a blood sample using a simple finger-stick methodology in the privacy of their home inFoods® IBS test is the first of its kind to identify
2y agoBMRABiomerica Announces inFoods® IBS Pilot Launch with Prominent 1,100 Member Physician Group Commencing June 2024GlobeNewswireWith IBS affecting 10 to 15% of the global population, the associated $21 billion in direct medical costs and absenteeism underscores the urgent need of innovative solutions. Recognized as the 7th most common diagnosis
2y agoBMRABiomerica and Leading UAE Healthcare Company Forge a Path to Enhanced Colorectal and Breast Screening with Exclusive Multi-Year Distribution AgreementGlobeNewswireDubai Healthcare Authority Granted Insurance Reimbursement for Biomerica's EZ Detect™ Colon Disease Screening Test EZ Detect™ is a simple FDA cleared 2-minute at-home test that detects early warning signs
2y agoBMRABiomerica provides update on inFoods® IBS expansionGlobeNewswire- Expansion into new offices within current major groups, including Northeast and Ohio; Expansion into new major group in Texas. - Average quarterly increase in physicians prescribing inFoods more than doubled each
2y agoBMRABiomerica Reports Third Quarter 2024 Financial ResultsGlobeNewswireFiscal Discipline Leads to Improvement as Loss per Share Narrows to $0.27 from $0.40 Amidst Sales Force Expansion for the Nine Months in Fiscal 2024 InFoods IBS Positive Clinical Data to be Presented at the Upcoming
2y agoBMRABiomerica InFoods IBS Data to be Presented at the Upcoming Digestive Disease Week (DDW) 2024 ConferenceGlobeNewswireCollaborators at the University of Michigan will present new Data on InFoods® IBS in the DDW Irritable Bowel Syndrome (IBS) Clinical Session IRVINE, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc.